Quaternary heteroatom containing compounds
US-10035769-B2 · Jul 31, 2018 · US
Glucose metabolism modulating compounds
US9012471B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9012471-B2 |
| Application number | US-93717709-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 10, 2009 |
| Priority date | Apr 11, 2008 |
| Publication date | Apr 21, 2015 |
| Grant date | Apr 21, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides, inter alia, dihydropyridone compounds and compositions, including analogs of a vesicular monoamine transporter type 2 (VMAT2) antagonist. The present invention also provides methods of using such compounds/analogs for modulating glucose levels, and/or preventing, treating, or ameliorating the effects of diabetes and hyper-glycemia.
First claim
Opening claim text (preview).
What is claimed is: 1. A compound of formula II: wherein R 1 , R 2 , R 3 , R 8 and R 9 are independently selected from the group consisting of H, halogen, C 1 -C 8 alkyl, C 1 -C 8 alkenyl, and C 1 -C 8 alkynyl; R 4 and R 5 , which are attached to one or more positions of at least one carbon atom of the respective rings, are independently selected from the group con…
Assignees
Inventors
Classifications
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
- C07D211/88Primary
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
- C07D211/86Primary
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9012471B2 cover?
- The present invention provides, inter alia, dihydropyridone compounds and compositions, including analogs of a vesicular monoamine transporter type 2 (VMAT2) antagonist. The present invention also provides methods of using such compounds/analogs for modulating glucose levels, and/or preventing, treating, or ameliorating the effects of diabetes and hyper-glycemia.
- Who is the assignee on this patent?
- Harris Paul, Maffei Antonella, Xie Yuli, and 2 more
- What technology area does this patent fall under?
- Primary CPC classification C07D211/88. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).